Found 473 articles for: "atopic dermatitis"
Efficacy of Dupilumab in Different Racial Subgroups of Adults With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials
August 2019 | Volume 18 | Issue 8 | Original Article | 804 | Copyright © August 2019
Dupilumab, a monoclonal antibody that blocks the shared receptor subunit for interleukin (IL)-4 and IL-13, is currently approved for the treatment of adults with inadequately controlled moderate-to-se...
Read MoreTwo Multicenter, Randomized, Double-Blind, Parallel Group Comparison Studies of a Novel Foam Formulation of Halobetasol Propionate, 0.05% vs Its Vehicle in Adult Subjects With Plaque Psoriasis
August 2019 | Volume 18 | Issue 8 | Original Article | 790 | Copyright © August 2019
Background: A novel foam formulation of halobetasol propionate, 0.05% (HBP-Foam) has been developed to treat plaque psoriasis in patients who prefer a thermostable topical foam with l...
Read MoreA Review of Topical Corticosteroid Foams
August 2019 | Volume 18 | Issue 8 | Original Article | 756 | Copyright © August 2019
Background: Topical corticosteroids are efficacious treatment options for multiple dermatoses. However, ointments and cream corticosteroid vehicles can be cumbersome to patients and m...
Read MoreARTICLE: IL-23 Versus IL-17 in the Pathogenesis of Psoriasis: There Is More to the Story Than IL-17A
August 2019 | Volume 18 | Issue 8 | Supplement Individual Articles | 202 | Copyright © August 2019
Our understanding of psoriasis pathogenesis has evolved considerably. Cytokines within the TH1 and TH17 pathways have been found to be critical in psoriasis immunopathology. The TH17 pathway, which is...
Read MoreTopical Ozenoxacin Cream 1% for Impetigo: A Review
July 2019 | Volume 18 | Issue 7 | Original Article | 655 | Copyright © July 2019
Background: Impetigo, a bacterial infection that is highly contagious, involves the superficial skin. Topical treatment for impetigo includes amongst other bacitracin, g...
Read MoreConnecting the Dots: From Skin Barrier Dysfunction to Allergic Sensitization, and the Role of Moisturizers in Repairing the Skin Barrier
June 2019 | Volume 18 | Issue 6 | Original Article | 581 | Copyright © June 2019
The skin is one of the largest immunologic organs in the body and a continuous target for allergic and immunologic responses. Impairment of the skin barrier increases the likelihood of external antige...
Read MoreValidation of Botanical Treatment Efficiency for Adults and Children Suffering from Mild to Moderate Atopic Dermatitis
June 2019 | Volume 18 | Issue 6 | Original Article | 557 | Copyright © June 2019
Objective: The study was conducted to determine the efficiency of the botanicals combination incorporated in the Kamedis Eczema Therapy Cream (the tested product) for adults and child...
Read MorePatient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study
June 2019 | Volume 18 | Issue 6 | Original Article | 514 | Copyright © June 2019
Background: Patients with skin of color (SOC) and Fitzpatrick skin types (FST) IV–VI frequently develop acne.
Objective: Evaluate subject-reported o...
Read MoreRed Deer Umbilical Cord Lining Mesenchymal Stem Cell Extract Cream for Rejuvenation of the Face
April 2019 | Volume 18 | Issue 4 | Original Article | 363 | Copyright © April 2019
BACKGROUND: Aging is a multifactorial process that involves all components of the skin. Both intrinsic and extrinsic forces play a role in this aging process. A new patented protein mix derived fr...
Read MoreAssessing the Synergistic Effect of a Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion in Moderate-to-Severe Plaque Psoriasis
March 2019 | Volume 18 | Issue 3 | Original Article | 279 | Copyright © March 2019
BACKGROUND: Fixed combinations are commonplace in dermatology, providing significant efficacy and tolerability benefits. In some cases, two active ingredients complement each other providing a cumu...
Read MoreLow Dose Naltrexone in Dermatology
March 2019 | Volume 18 | Issue 3 | Original Article | 235 | Copyright © March 2019
Low-dose naltrexone (LDN) has been successfully studied as an immunomodulatory and anti-inflammatory therapy in a wide ...
Read MoreAtopic Dermatitis: A Review of Topical Treatment
February 2019 | Volume 18 | Issue 2 | Department | 110 | Copyright © February 2019
Atopic dermatitis affects up to 20% of children and continues to increase in prevalence. Effective disease control is aimed at decreasing symptoms and reducing the frequency of flares, which may be co...
Read MoreTopical Treatment for the Management of Atopic Dermatitis
February 2019 | Volume 18 | Issue 2 | Supplement Individual Articles | 112 | Copyright © February 2019
Atopic dermatitis affects up to 20% of children and continues to increase in prevalence. Effective disease control is aimed at decreasing symptoms and reducing the frequency of flares, which may be co...
Read MoreManagement of Atopic Dermatitis
February 2019 | Volume 18 | Issue 2 | Supplement Individual Articles | 111 | Copyright © February 2019
Atopic Dermatitis (AD) is estimated to affect 15-20% of children and remains a major health consideration for pediatricians and dermatologists.1 Over the past three decades, studies have shown an incr...
Read MoreA Case of Complete Resolution of Severe Plantar Dyshidrotic Eczema With Dupilumab
February 2019 | Volume 18 | Issue 2 | Editorials | 211 | Copyright © February 2019
A 44-year-old woman with a history of asthma, hypercholesterolemia, and impaired glucose tolerance presented with severely painful and intensely pruritic plantar dermatitis for more than two years tha...
Read MoreA Review of the Dermatologic Symptoms of Idiopathic Mast Cell Activation Syndrome
February 2019 | Volume 18 | Issue 2 | Original Article | 162 | Copyright © February 2019
Since the first reported cases in 2007, idiopathic mast cell activation syndrome has been increasingly recognized. Understanding of the cutaneous manifestations of this condition is imperative for der...
Read MoreSystemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in Practice
February 2019 | Volume 18 | Issue 2 | Original Article | 122 | Copyright © February 2019
Atopic dermatitis (AD) is a chronic inflammatory skin disease that affects around 13% of children and 7% of adults in the US. It can have a significant impact on the quality of life (QoL) of affected ...
Read MorePrinciples of Moisturizer Product Design
January 2019 | Volume 18 | Issue 1 | Supplement Individual Articles | 89 | Copyright © January 2019
Moisturizers provide significant benefit in dermatology – as adjuvant therapy for many clinical conditions, as a key player in anti-aging regimens, and as a core component in maintaining healthy ski...
Read MoreRecent Advances in Mild and Moisturizing Cleansers
January 2019 | Volume 18 | Issue 1 | Supplement Individual Articles | 80 | Copyright © January 2019
Mild and moisturizing cleanser technologies, and the science underpinning them, have progressed significantly over the past decade. This includes introduction of amino-acid based milder surfactants in...
Read MoreThe Importance of Understanding Consumer Preferences for Dermatologist Recommended Skin Cleansing and Care Products
January 2019 | Volume 18 | Issue 1 | Supplement Individual Articles | 75 | Copyright © January 2019
Dermatologist recommendations of skin care products are critical to the management of compromised and healthy skin and appreciated by patients. Professionals must carefully weigh not only the safety a...
Read More